Consortium of Multiple Sclerosis Centers 2015 Annual Meeting
The revised guidelines stress the use of high-quality imaging and consistency in images taken.
People with MS who have comorbidities may be more likely to experience disruptive pain.
Another study suggests that a telehealth system could help objectively monitor dose adherence.
Rates were similar, but gender and age-specific differences emerged.
Insurance coverage can be the determining factor on whether a patient receives DMT or not.
A team to address both the physical and emotional outcomes of MS relapse is essential to high quality care.
A combination of physical, occupational, hand, speech, cognitive, and behavioral therapy improves outcomes.
Sign Up for Free e-newsletters
Check out what's trending
Neurology Advisor Articles
- US Opioid Overdose Deaths Reach Record Number
- Migraine Treatment in the ED: Overcoming Our Penchant for Opioids
- Erenumab as a Therapy for Hard to Treat Episodic Migraine
- Abnormalities in Genes Linked to IRSP in Alzheimer Disease
- Recommended Levels of Cardiovascular Risk Factors Associated With Cerebral Vessel Density, Flow
- New Diagnostic Criteria for Neurosarcoidosis: What You Need to Know
- Guideline for Diagnosis and Treatment of Idiopathic Intracranial Hypertension
- Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine
- Ivy League Rule Change Linked to Fewer Concussions During NCAA Football Games
- Addressing Levodopa-Resistant Parkinson Disease
- High Daily Stress Linked to Migraine Prevalence in Women
- Researchers Identify Coffee Component That May Provide Neuroprotection
- Functional Imaging in Movement Disorders: Diagnostic Advantages
- Dextroamphetamine Plus Physical Therapy Nonsuperior to Placebo for Improving Post-Stroke Motor Recovery
- Nusinersen May Be Effective for Short-Term Motor Function Improvements in Spinal Muscular Atrophy